HITI Canna Cabana Quarterly EPS earnings growth

Corporate company logo of Canna Cabana (HITI)

High Tide Inc. (HITI) is facing pricing pressure and legislative barriers that necessitate higher working capital. The quarterly growth rate of net income per share visualizes these challenges, where the value 1650.50 reflects the current trend. Due to cyclical flows and competition, margin stability remains uncertain. To optimize business momentum, High Tide Inc. is implementing predictive AI and warehouse logistics automation.

hightideinc.com (HITI) - Year-over-year net earnings per share change for the last twelve months from 07/04/2022 to 11/14/2026

Canna Cabana (HITI) - metric breakdowns and financial figures

- market value and analyst target forecast:
Summary company analytics:High Tide, HITI
Flagship merchandise of hightideinc.com

A comparative asset analysis requires verifying real returns through net income dynamics. This metric measures the percentage change in earnings per share between consecutive quarters, identifying systemic business degradation or growth. For High Tide Inc. (HITI), this reflects the efficiency of its retail network and cannabis e-commerce sales. A positive trend confirms operational resilience. By analyzing the quarterly EPS growth index, an investor avoids a value trap.

Competitor analysis for High Tide Inc.

Indivior (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharma|CRON (Cronos) - Quarterly EPS earnings growth|CGC: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACB|Year-over-year net earnings per share change for the last twelve months achievelifesciences.com|Quarterly EPS earnings growth SKYE (Skye Bioscience, Inc.)|Net earnings per share growth for the trailing year Anebulo Pharmaceuticals Inc|Canndoc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NTRB (Nutriband Inc.)|NSRX (nasuspharma.com) - Year-over-year net earnings per share growth for the last 12 months|IGC Pharma - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months MIRA|FLGC (Flora Growth Corp) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth IMCC|Year-over-year net earnings per share change for the last twelve months adialpharma.com|Quarterly EPS earnings growth ARTL (Artelo Biosciences, Inc.)|ENSC: Year-over-year earnings per share growth for the last 12 months|Titan Pharma - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings, Inc.|INM (InMed Pharma) - Year-over-year net earnings per share growth for the last 12 months|Akanda Inc - Year-over-year earnings per one share growth for the last 12 months|ENVB (Enveric Biosciences) - Quarterly EPS earnings growth|Bright Green Corp (BGXX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Hempacco (HPCO)